Alkermes

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.

The brain implant company cofounded by Elon Musk is moving to trademark several product names, including Telepathy and Telekinesis.

Iktos, a global leader in AI-driven drug discovery, has secured a prestigious €2.5 million grant from the European Innovation Council (EIC) Accelerator to advance its AI and robotics synthesis automation technology.

Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare industry. Just last month, AWS and General Catalyst announced their partnership to speed up the development and deployment of healthcare AI tools.

During a fireside chat at the annual J.P. Morgan Healthcare Conference on January 13th, Mayo Clinic chief administrative officer Christina Zorn shared how the company addresses potential future healthcare worker shortages and improves cancer care by leveraging AI in robotics and pathology database management.

Isomorphic was spun out of Google's AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its parent company, Alphabet. The start-up's potential has attracted big pharmaceutical partners, which are keen to lower expenses and boost efficiency of the costly drug development process.

Trained on large databases of brain data among newborns, CergenX's Wave device uses AI to help with earlier detection of brain injury.

The capital injection will be channelled into expanding Cera's AI-driven platform, which predicts health deterioration.